These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8227 related articles for article (PubMed ID: 24246920)

  • 1. [Role of arginase-1 expression in distinguishing hepatocellular carcinoma from non-hepatocellular tumors].
    Sang W; Gulinar A; Wang CH; Sheng WQ; Maiweilidan Y; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):538-42. PubMed ID: 24246920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte differentiation markers in adenocarcinoma of the prostate: hepatocyte paraffin 1 but not arginase-1 is specifically expressed in a subset of prostatic adenocarcinoma.
    Giedl J; Büttner-Herold M; Wach S; Wullich B; Hartmann A; Agaimy A
    Hum Pathol; 2016 Sep; 55():101-7. PubMed ID: 27184483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginase-1 is a more sensitive marker than HepPar-1 and AFP in differential diagnosis of hepatocellular carcinoma from nonhepatocellular carcinoma.
    Sang W; Zhang W; Cui W; Li X; Abulajiang G; Li Q
    Tumour Biol; 2015 May; 36(5):3881-6. PubMed ID: 25577247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginase-1 is frequently positive in hepatoid adenocarcinomas.
    Chandan VS; Shah SS; Torbenson MS; Wu TT
    Hum Pathol; 2016 Sep; 55():11-6. PubMed ID: 27137985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA; Ahmed NS
    Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
    Li J; Wei L
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms.
    Yan BC; Gong C; Song J; Krausz T; Tretiakova M; Hyjek E; Al-Ahmadie H; Alves V; Xiao SY; Anders RA; Hart JA
    Am J Surg Pathol; 2010 Aug; 34(8):1147-54. PubMed ID: 20661013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens.
    Timek DT; Shi J; Liu H; Lin F
    Am J Clin Pathol; 2012 Aug; 138(2):203-10. PubMed ID: 22904131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of expressions of Arg-1, Hep Par-1, and CK19 in the diagnosis of the primary hepatocellular carcinoma subtypes and exclusion of the metastases.
    Atta IS
    Histol Histopathol; 2021 Sep; 36(9):981-993. PubMed ID: 34254284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diagnostic Value of Arginase-1, FTCD, and MOC-31 Expression in Early Detection of Hepatocellular Carcinoma (HCC) and in Differentiation Between HCC and Metastatic Adenocarcinoma to the Liver.
    Labib OH; Harb OA; Khalil OH; Baiomy TA; Gertallah LM; Ahmed RZ
    J Gastrointest Cancer; 2020 Mar; 51(1):88-101. PubMed ID: 30784016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver.
    Geramizadeh B; Seirfar N
    Hepat Mon; 2015 Jul; 15(7):e30336. PubMed ID: 26300935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Well differentiated arginase-1 negative hepatocellular carcinoma.
    Obiorah IE; Chahine J; Park BU; Ko K; deGuzman J; Kallakury B
    Transl Gastroenterol Hepatol; 2019; 4():66. PubMed ID: 31620648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies.
    Fujiwara M; Kwok S; Yano H; Pai RK
    Cancer Cytopathol; 2012 Aug; 120(4):230-7. PubMed ID: 22434791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hep par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections.
    Fan Z; van de Rijn M; Montgomery K; Rouse RV
    Mod Pathol; 2003 Feb; 16(2):137-44. PubMed ID: 12591966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
    McKnight R; Nassar A; Cohen C; Siddiqui MT
    Cancer Cytopathol; 2012 Aug; 120(4):223-9. PubMed ID: 22298472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
    Shahid M; Mubeen A; Tse J; Kakar S; Bateman AC; Borger D; Rivera MN; Ting DT; Deshpande V
    Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative.
    Clark I; Shah SS; Moreira R; Graham RP; Wu TT; Torbenson MS; Chandan V
    Hum Pathol; 2017 Nov; 69():90-95. PubMed ID: 28970136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver.
    Ibrahim TR; Abdel-Raouf SM
    Pathol Oncol Res; 2015 Apr; 21(2):379-87. PubMed ID: 25108409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginase-1: a highly specific marker separating pancreatic adenocarcinoma from hepatocellular carcinoma.
    Fatima N; Cohen C; Siddiqui MT
    Acta Cytol; 2014; 58(1):83-8. PubMed ID: 24281232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alanine-glyoxylate aminotransferase 1 (AGXT1) is a novel marker for hepatocellular carcinomas.
    Zhao CL; Hui Y; Wang LJ; Yang D; Yakirevich E; Mangray S; Huang CK; Lu S
    Hum Pathol; 2018 Oct; 80():76-81. PubMed ID: 29883780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 412.